Literature DB >> 33436419

How the Oxford-AstraZeneca covid-19 vaccine was made.

Elisabeth Mahase1.   

Abstract

Entities:  

Year:  2021        PMID： 33436419     DOI： 10.1136/bmj.n86

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  6 in total

Review 1.  Pityriasis rosea-like cutaneous eruption as a possible dermatological manifestation after Oxford-AstraZeneca vaccine: Case report and brief literature review.

Authors:  Maria Cristina Pedrazini; Mariliza Henrique da Silva
Journal:  Dermatol Ther       Date:  2021-09-25       Impact factor: 3.858

Review 2.  Chitosan Nanoparticles for Antiviral Drug Delivery: A Novel Route for COVID-19 Treatment.

Authors:  Abdel-Majed Safer; Stefano Leporatti
Journal:  Int J Nanomedicine       Date:  2021-12-16

Review 3.  Scope of SARS-CoV-2 variants, mutations, and vaccine technologies.

Authors:  Josephine Wambani; Patrick Okoth
Journal:  Egypt J Intern Med       Date:  2022-03-26

4.  Infection kinetics of Covid-19 and containment strategy.

Authors:  Amit K Chattopadhyay; Debajyoti Choudhury; Goutam Ghosh; Bidisha Kundu; Sujit Kumar Nath
Journal:  Sci Rep       Date:  2021-06-02       Impact factor: 4.379

5.  Safety of ChAdOx1 nCoV-19 Vaccine: Independent Evidence from Two EU States.

Authors:  Abanoub Riad; Andrea Pokorná; Mohamed Mekhemar; Jonas Conrad; Jitka Klugarová; Michal Koščík; Miloslav Klugar; Sameh Attia
Journal:  Vaccines (Basel)       Date:  2021-06-18

6.  Post-COVID-19 vaccination occurrence of splenic infarction due to arterial thrombosis.

Authors:  Alexander Anderson; Mary Seddon; Khalid Shahzad; Raimundas Lunevicius
Journal:  BMJ Case Rep       Date:  2021-12-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.